Next Oncology-Dallas is a clinical research site located in Irving, Texas, United States 75039.
Crixeo Clinical Trials Trust Score: 22/100 (FAILING). This profile has not yet been claimed by the site owner.
Next Oncology-Dallas has participated in 24 clinical trials with 20 currently active.
Therapeutic areas: Advanced Solid Tumor, Non Small Cell Lung Cancer, Breast Cancer.
Sponsors: Aprea Therapeutics, MediLink Therapeutics (Suzhou) Co., Ltd., IconOVir Bio.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Irving
Trust Score: 22/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Next Oncology-Dallas has a Crixeo Trust Score of 22/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Next Oncology-Dallas has 24 clinical trials on record, with 20 currently active. Their work covers Advanced Solid Tumor, Non Small Cell Lung Cancer, Breast Cancer.
Next Oncology-Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.